Page 1,951«..1020..1,9501,9511,9521,953..1,9601,970..»

Stem cell transplant 'very encouraging' for type 1 …

Posted: November 2, 2014 at 3:52 pm

A handful of people with type 1 diabetes have been able to survive without insulin shots for more than two-and-a-half years, on average, after having their own blood stem cells removed and reimplanted through intravenous injection, U.S. and Brazilian researchers reported Tuesday.

Patients had their own blood stem cells removed and reimplanted through intravenous injection.

Overall, the technique has been tried in 23 people, mostly boys and young men, who were treated within six weeks of a new diagnosis of type 1 diabetes. People who have type 1 diabetes, an autoimmune disease that destroys the insulin-producing cells in the pancreas, typically need insulin shots to survive. (People with type 1 make up only about 10 percent of all diabetics; most people have type 2, which can be controlled with diet, exercise, oral drugs, or insulin shots.)

After the transplant, 20 of the 23 patients became insulin-free for at least a few months or even years. Twelve of them stayed free of insulin for an average of 31 months and eight patients had periods ranging from six to 47 months in which they were free from insulin. Health.com: A surprising new lip benefit -- stem cells

One patient was free of daily insulin for more than four years before needing insulin shots, according to the report in the Journal of the American Medical Association. The stem cell transplants were performed at a single center in Brazil.

The new findings are "very encouraging," says Dr. Richard K. Burt, associate professor of medicine at Northwestern University's Feinberg School of Medicine, who presented the findings at a Washington press briefing. Still, he said, more study is needed before it's known whether the treatment truly alters the course of the disease. "I never use the word 'cure,'" says Burt, who is also chief of the Division of Immunotherapy and Autoimmune Diseases at Northwestern Memorial Hospital in Chicago, Illinois. "We just have to wait and see."

Two years ago, Burt and colleagues showed that 14 of 15 patients (who were also included in the new study) treated this way were able to go without insulin injections for one to 35 months, but it wasn't clear if this was due to closer medical follow-up and lifestyle changes. In the new study, the researchers measured a protein that suggested the patients did indeed have insulin-producing beta cells, which are typically destroyed by the autoimmune disease.

So far, stem cell transplantation is the only therapy shown to reverse type 1 diabetes in humans, the research team noted. Health.com: Eating to control cholesterol -- everyday diet strategies to lower LDL

However, Dr. Mohamed El-Shahawy, a transplant nephrologist and a member of the islet cell transplantation team at City of Hope in Duarte, California, cited a number of concerns around the study and risks to patients.

"This study basically subjects patients to an unproven high-risk procedure," he said. "Could it be a breakthrough? I don't see it."

Read the original here:
Stem cell transplant 'very encouraging' for type 1 ...

Posted in Wyoming Stem Cells | Comments Off on Stem cell transplant 'very encouraging' for type 1 …

Stem Cell Therapy | stem cell mobilization gcsf – Video

Posted: November 2, 2014 at 3:46 pm


Stem Cell Therapy | stem cell mobilization gcsf
http://www.arthritistreatmentcenter.com Another breakthrough in stem cell science and we have lab rats to thank for it next Osteoarthritis in rats responds to stem cell mobilization therapy...

By: Nathan Wei

Continued here:
Stem Cell Therapy | stem cell mobilization gcsf - Video

Posted in Stem Cell Therapy | Comments Off on Stem Cell Therapy | stem cell mobilization gcsf – Video

Letter: Adult stem cells can change the healthcare landscape

Posted: November 1, 2014 at 11:46 pm

Adult stem cells can change the healthcare landscape

A recent Colorado political advertisement highlighting a candidates stance on stem cell research shows the issue is still at the forefront of public consciousness. Part of what makes stem cell research such a hot button issue is the number of persistent myths that propagate many of the heated emotions surrounding the topic.

Much of the stem cell controversy comes from the fact many people only know of embryonic stem cells, which are generated from fertilized, frozen eggs at in-vitro fertilization centers. These are not the only type of stem cells. Other types include umbilical cord blood and adult stem cells.

Umbilical cord blood is extracted from birth and preserved for the future benefit of the child. While this type of stem cell technique is safe and it is becoming commonplace to store the cells, there is currently no way to utilize these cells beyond compassionate care cases which are few and far between. However, adult stem cells are currently in clinical use today and are easily and safely harvested from the patients fat and bone marrow reserves. The adult stem cells can be utilized for a variety of treatment options, which include joint, ligament and tendon injuries, back pain, and autoimmune diseases.

Polls indicate a shifting paradigm in how people view stem cell use and research. A Pew Research survey conducted in 2013 revealed only 16 percent believed non-embryonic stem cell research was immoral. Pope Emeritus Benedict XVI recently gave his approval on adult stem cell research, I pray that your commitment to adult stem cell research will bring great blessings for the future of man and genuine enrichment to his culture.

Those with an understanding of adult stem cells know there is no controversy as they do not require the harming of an embryo. While progress in the realm of public opinion is being made, regulatory and administrative difficulties are still hampering medical innovation according to some healthcare experts.

Adult stem cells hold great promise for the future of medicine because of their potential to improve cartilage health, repair lumbar discs, and slow progression of autoimmune diseases. The ability to utilize stem cells from ones own body to safely and naturally heal itself from many different ailments is beginning to revolutionize healthcare.

With more public support and cooperative regulatory policies, adult stem cells have the potential to forever change the healthcare landscape as profoundly as the mark antibiotics made on medicine.

Dr. Scott Brandt

ThriveMD Aspen

Read more:
Letter: Adult stem cells can change the healthcare landscape

Posted in Stem Cells | Comments Off on Letter: Adult stem cells can change the healthcare landscape

Study of Human Neural Stem Cells – Video

Posted: November 1, 2014 at 7:43 pm


Study of Human Neural Stem Cells
I created this video with the YouTube Video Editor (http://www.youtube.com/editor)

By: Mind, Body Soul

Read the rest here:
Study of Human Neural Stem Cells - Video

Posted in Stem Cell Videos | Comments Off on Study of Human Neural Stem Cells – Video

ZEISS LSM 880 with Airyscan: Human intestinal stem cells – Video

Posted: November 1, 2014 at 7:43 pm


ZEISS LSM 880 with Airyscan: Human intestinal stem cells
Human intestinal stem cell derived enteroid monolayer. Staining: Green - F-actin by phalloidin; red - alpha-fodrin protein. 3D imaging comparing confocal wit...

By: ZeissMicroscopy

View post:
ZEISS LSM 880 with Airyscan: Human intestinal stem cells - Video

Posted in Stem Cell Videos | Comments Off on ZEISS LSM 880 with Airyscan: Human intestinal stem cells – Video

Dr Vincent Giampapa interviewed on the TODAY Morning Show Sydney, Australia – Video

Posted: November 1, 2014 at 7:43 pm


Dr Vincent Giampapa interviewed on the TODAY Morning Show Sydney, Australia
Interview with Dr. Vincent Giampapa, medical advisor at Jeunesse, who was recently nominated for a 2014 Nobel Prize in the area of Stem Cell Research. For more information go to ...

By: Corina Downie

Read more from the original source:
Dr Vincent Giampapa interviewed on the TODAY Morning Show Sydney, Australia - Video

Posted in Stem Cell Research | Comments Off on Dr Vincent Giampapa interviewed on the TODAY Morning Show Sydney, Australia – Video

Cell Expansion Market Worth $14.8 Billion by 2019

Posted: November 1, 2014 at 10:47 am

DALLAS, October 29, 2014 /PRNewswire/ --

According to the new market research report The"Cell Expansion Marketby Product (Reagent, Media, Serum, Bioreactors, Centrifuge), Cell Type (human, animal), Application (Stem Cell Research, Regenerative Medicine, Clinical Diagnostics), End User (Hospital, Biotechnology, Cell Bank) - Forecast to 2019", published by MarketsandMarkets, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Cell Expansion Market along with the estimates and forecasts of the revenue and share analysis.

Browse 149 Market Data Tables and 56 Figures spread through 224 Pages and in-depth TOC on"Cell Expansion Market"

http://www.marketsandmarkets.com/Market-Reports/cell-expansion-market-194978883.html

Early buyers will receive 10% customization on this report.

The global Cell Expansion Market is expected to reach $14.8 Billion by 2019 from $6.0 Billion in 2014, growing at a CAGR of 19.7% from 2014 to 2019.

The report segments this market on the basis of product, cell type, application, and end user. Among various applications, the regenerative medicines is expected to account for the largest share in 2014 and is expected to account for the fastest-growing segment in the cell expansion market, owing to technological advancement due to which new products are being launched in the market. Furthermore, rising investments by companies and government for research is another major reason for the growth of this market.

Based on geography, the global Cell Expansion Market is segmented into North America, Europe, Asia, and Rest of the World (RoW). North America is expected to account for the largest share of the market by the end of 2014. The large share of this region can be attributed to various factors including increasing government support for cancer and stem cell research and increasing prevalence of chronic diseases in this region.

Further Inquiry:http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=194978883

Prominent players in the Cell Expansion Market are Becton, Dickinson and Company (U.S.), Corning Incorporated (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.K.), Merck Millipore (U.S.), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Sigma-Aldrich Corporation (U.S.), Terumo BCT (U.S.), and Thermo Fisher Scientific Inc. (U.S.).

More:
Cell Expansion Market Worth $14.8 Billion by 2019

Posted in Cell Medicine | Comments Off on Cell Expansion Market Worth $14.8 Billion by 2019

Decoding the emergence of metastatic cancer stem cells

Posted: November 1, 2014 at 4:46 am

From our community

In the first study of its kind, Rice University researchers have mapped how information flows through the genetic circuits that cause cancer cells to become metastatic. The research reveals a common pattern in the decision-making that allows cancer cells to both migrate and form new tumors. Researchers say the commonality may open the door to new drugs that interfere with the genetic switches that cancer must flip to form both cancer stem cells and circulating tumor cells -- two of the main players in cancer metastasis.

"Cells have genetic circuits that are used to switch certain behaviors on and off," said biophysicist Eshel Ben-Jacob, a senior investigator at Rice's Center for Theoretical Biological Physics and co-author of a new study in the Journal of the Royal Society Interface. "Though some of the circuits for metastasis have been mapped, this is the first study to examine how cancer uses two of those circuits, in concert, to produce not just cancer stem cells, but also dangerous packs of hybrid stem-like-cells that travel in groups to colonize other parts of the body."

Metastasis -- the spread of cancer between organs -- causes more than 90 percent of cancer deaths, but not all tumor cells can metastasize. The switch that many cancer cells use to become metastatic is the circuit that governs the epithelial-to-mesenchymal transition, or EMT. The EMT, an important feature in embryonic development and wound healing, allows cells to revert back along their developmental path and take on certain stem-like features that allow them to form new tissues and repair tissue damage.

Cancer cells co-opt the EMT process to allow tumor cells to break away and migrate to other parts of the body. Once there, the cells reverse the switch and transition back to epithelial cells to form a new colony.

In 2013, Ben-Jacob and Rice colleagues Jos Onuchic, Herbert Levine, Mingyang Lu and Mohit Kumar Jolly discovered that cancer uses the EMT circuitry as a three-way switch. Rather than simply flipping between the epithelial (E) and mesenchymal (M) states, the study showed that cancer had the ability to form E-M hybrids.

In the new study, Ben-Jacob, Levine, Jolly and Lu teamed with Rice graduate student Bin Huang and the University of Texas MD Anderson Cancer Center's Sendurai Mani to examine the interaction between the three-way EMT switch and a second, well-documented genetic switch that gives rise to cancer stem cells (CSCs). The research showed that the CSC circuit also operates as a three-way switch. In addition, the study found "significant correspondence" between the operation of the two switches, which suggests a mechanism that would confer "stemness" on hybrid E-M cancer cells that are known to travel in packs called circulating tumor cells (CTCs).

"According to the prevailing cancer dogma, cells that become fully mesenchymal pose the highest risk of metastasis progression," said Ben-Jacob, adjunct professor of biosciences at Rice. "Indeed, most diagnostic and therapeutic efforts to date have focused on targeting these cells. Notwithstanding that the hybrid cells are more versatile and have the advantage of moving together as a group, they have been assumed to be less harmful than their fully mesenchymal cousins. Our discovery -- that squads of hybrid cancer cells also have 'stemness' characteristics -- challenges this picture."

Jolly, the study's first author, said, "By applying a physics-based approach to understand the dynamics of cancer decision-making, we were able to explain a number of recent experimental observations, including some that seemed contradictory."

Mani, who first showed in 2008 that the EMT switch could produce cells with stem-like properties, said, "Being stem-like means that cells can easily differentiate back to epithelial as well as change their character to found a whole colony of specialist cells that work together. The finding of 'stemness' in E-M hybrids means that those cells will have a better chance to form metastases because they can more easily adapt to newly encountered conditions and become E cells easily at the metastasic niche in a distant organ."

Read the original post:
Decoding the emergence of metastatic cancer stem cells

Posted in Stem Cells | Comments Off on Decoding the emergence of metastatic cancer stem cells

Adler Footcare – Stem Cell Therapy – Video

Posted: November 1, 2014 at 4:40 am


Adler Footcare - Stem Cell Therapy
Backed by years of research, thousands of happy patients, and faster healing time is the latest in ethical stem cell treatments for foot pain offered at Adle...

By: Adler Footcare

The rest is here:
Adler Footcare - Stem Cell Therapy - Video

Posted in Cell Therapy, Stem Cell Therapy | Comments Off on Adler Footcare – Stem Cell Therapy – Video

Stem Cell Therapy BACKSTAGE – Video

Posted: November 1, 2014 at 4:40 am


Stem Cell Therapy BACKSTAGE

By:

Link:
Stem Cell Therapy BACKSTAGE - Video

Posted in Stem Cell Therapy | Comments Off on Stem Cell Therapy BACKSTAGE – Video

Page 1,951«..1020..1,9501,9511,9521,953..1,9601,970..»